Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-25 @ 9:21 PM
Study NCT ID:
NCT00318656
Status:
COMPLETED
Last Update Posted:
2009-05-07
First Post:
2006-04-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11
Start Date Type:
None
Primary Completion Date:
2007-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-25
First Submit QC Date:
None
Study First Post Date:
2006-04-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2008-10-17
Results First Submit QC Date:
None
Results First Post Date:
2009-03-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-04-10
Last Update Post Date:
2009-05-07
Last Update Post Date Type:
ESTIMATED